2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Meticular
Category
Website - Nonprofit
Country / Region
United States
Entrant Company
Finalsite
Category
Website - School / Universities
Country / Region
United States
Entrant Company
Zhang Ning
Category
Corporate Identity - Logos
Country / Region
China
Entrant Company
Launch
Category
Website - Business to Business
Country / Region
United States